Statins as Potential Antimalarial Drugs: Low Relative Potency and Lack of Synergy with Conventional Antimalarial Drugs

Statins as Potential Antimalarial Drugs: Low Relative Potency and Lack of Synergy with Conventional Antimalarial Drugs Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum Statins Alone Are Ineffective in Cerebral Malaria but Potentiate Artesunate New pentasubstituted pyrrole hybrid atorvastatin–quinoline derivatives with antiplasmodial activity Synergy of Human Immunodeficiency Virus Protease Inhibitors with Chloroquine against Plasmodium falciparum In Vitro and Plasmodium chabaudi In Vivo In Vitro Antimalarial Activity of Azithromycin, Artesunate, and Quinine in Combination and Correlation with Clinical Outcome Antiplasmodial activities of 4-aminoquinoline–statine compounds A novel artemisinin–quinine hybrid with potent antimalarial activity Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro